Diagnostic Value of Serological Markers and Quantitative Real-Time PCR in Patients With Invasive Candidiasis

MD ALI HOSSAIN, PENG Liang, YUAN Yu, ZHOU Xiaohan, MA Ying

Abstract


Objective 

 To evaluate the clinical diagnostic value of serological markers, including the 1, 3-β-D-glucan test (G-test), Candida mannan (Mn) antigen, Candida mannan IgG antibody (Mn-IgG), and quantitative real-time PCR(qPCR) in patients with invasive candidiasis (IC).

Methods 

 This study included 79 patients with culture-proven IC (IC group) and 83 patients without IC (non-IC group) at West China Hospital, Sichuan University between December 2022 and December 2024. Serum samples were tested for the G test (chemiluminescence), Mn antigen (ELISA), Mn-IgG (chemiluminescence), and qPCR. The diagnostic sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of individual and combined tests were calculated. Diagnostic performance was assessed using receiver operating characteristic (ROC) curve analysis.

Results 

The sensitivity, specificity, PPV, and NPV of the three serological markers for IC diagnosis when used individually were as follows: G test, 62.03%, 94.87%, 92.45%, and 71.15%; Mn antigen, 65.63%, 86.59%, 79.25%, and 76.34%; Mn-IgG antibody, 31.65%, 87.95%, 71.43%, and 57.48%. Combined detection of the G test, Mn antigen, and Mn-IgG increased sensitivity to 73.44%. Based on ROC curve analysis, the AUCs for diagnosing IC using each serological marker were: G test, 0.862 (95% CI: 0.803-0.922); Mn test, 0.853 (95% CI: 0.790-0.915); Mn-IgG, 0.603 (95% CI: 0.514-0.692). The combined AUCs for G test + Mn test, G test + Mn-IgG, and G test + Mn test + Mn-IgG were 0.875 (95% CI: 0.809-0.925), 0.869 (95% CI: 0.805-0.917), and 0.875 (95% CI: 0.809-0.924), respectively, demonstrating superiority over individual tests. The sensitivity, specificity, PPV, and NPV of qPCR for IC diagnosis were 100.00%, 98.80%, 98.75%, and 100.00%, respectively. Using culture strain identification by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) as the gold standard, qPCR demonstrated diagnostic concordance rates of 100.00% for Candida albicans, 100.00% for Candida tropicalis, 94.40% for Candida glabrata, and 90.00% for Candida parapsilosis.

Conclusion 

The combined use of the G test, Mn antigen, and Mn-IgG antibody increases diagnostic sensitivity and facilitates early diagnosis of IC. qPCR demonstrates excellent diagnostic performance for IC, enabling species-level identification of common Candida species associated with IC and detection of other Candida species. It also shows consistency with clinical culture methods.

 

Keywords: 1, 3-β-D-glucan, Candida mannan antigen,  Candida mannan IgG antibody,  Quantitative real-time PCR, Invasive candidiasis

 

Full Text:

PDF


References


DENNING D W. Global incidence and mortality of severe fungal disease. Lancet Infect Dis, 2024, 24(7): e428-e438. doi: 10.1016/S1473-3099(23) 00692-8.

NAVARATHNA D H, RACHUT E R, JINADATHA C, et al. Disseminated invasive candidiasis in an immunocompetent host. Fed Pract, 2019, 36(9): 425-429.

LIU L, WANG H, LIU N N. Advances in epidemiology and treatment of invasiveCandida infection in the immunocompromisedpopulation. J Shanghai Jiao Tong фUniv (Med Sci). 2021, 41(04): 525-529. doi: 10.3969/j. issn.1674-8115.2021.04.018.

QUINDOS G, MARCOS-ARIAS C, SAN-MILLAN R, et al. The continuous changes in the aetiology and epidemiology of invasive candidiasis: from familiar Candida albicans to multiresistant Candida auris. Int Microbiol, 2018, 21(3): 107-119. doi: 10.1007/s10123-018-0014-1.

PERLIN D S, RAUTEMAA-RICHARDSON R, ALASTRUEY-IZQUIERDO A. The global problem of antifungal resistance: prevalence, mechanisms, and management. Lancet Infect Dis, 2017, 17(12): e383-e392. doi: 10.1016/S1473-3099(17)30316-X.

XIAO M, CHEN S C, KONG F, et al. Distribution and Antifungal susceptibility of Candida Species Causing Candidemia in China: An update from the CHIF-NET study. J Infect Dis, 2020, 221(Suppl 2): S139-S147. doi: 10.1093/infdis/jiz573.

World Health Organization. WHO fungal priority pathogens list to guide research, development and public health action. Available from: https://www.who.int/publications/i/item/9789240060241

CORNELY O A, SPRUTE R, BASSETTI M, et al. Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM. Lancet Infect Dis, 2025, 25(5): e280-e293. doi: 10.1016/S1473-3099(24)00749-7.

MENDONCA A, SANTOS H, FRANCO-DUARTE R, et al. Fungal infections diagnosis - Past, present and future. Res Microbiol, 2022, 173(3): 103915. doi: 10.1016/j.resmic.2021.103915.

ZHU L P, GUAN X D, HUANG X J, et al. Chinese consensus on the diagnosis and management of adult candidiasis. Chinese Journal of the Frontiers of Medical Science (Electronic Version), 2020, 12(01): 35-50. doi: 10.12037/YXQY.2020.01-06.

DONNELLY J P, CHEN S C, KAUFFMAN C A, et al. Revision and update of the consensus definitions of invasive fungal disease from the european organization for research and treatment of cancer and the mycoses study group education and research consortium. Clin Infect Dis, 2020, 71(6): 1367-1376. doi: 10.1093/cid/ciz1008.

SHEN W, YANG W L, YE L Y, et al. The clinical value of G test in invasive candidiasis.Chin J Mycol, 2019, 14(2): 78-82. doi: 10.3969/j.issn. 1673-3827.2019.02.004.

TROVATO L, CALVO M, PALERMO C I, et al. The Role of the OLM CandID Real-Time PCR in the Invasive Candidiasis Diagnostic Surveillance in Intensive Care Unit Patients. Microorganisms, 2025, 13(3): 674. doi: 10.3390/microorganisms13030674.

KOC O, KESSLER H H, HOENIGL M, et al. Performance of Multiplex PCR and beta-1, 3-D-Glucan Testing for the Diagnosis of Candidemia. J Fungi (Basel), 2022, 8(9): 972. doi: 10.3390/jof8090972.

PRICE J S, FALLON M, POSSO R, et al. An Evaluation of the OLM CandID Real-Time PCR to Aid in the Diagnosis of Invasive Candidiasis When Testing Serum Samples. J Fungi (Basel), 2022, 8(9): 935. doi: 10. 3390/jof8090935.

NIETO M, ROBLES J C, CAUSSE M, et al. Polymerase Chain Reaction Versus Blood Culture to Detect Candida Species in High-Risk Patients with Suspected Invasive Candidiasis: The MICAFEM Study. Infect Dis Ther, 2019, 8(3): 429-444. doi: 10.1007/s40121-019-0248-z.

FELIX GN, de FREITAS VLT, da SILVA JUNIOR AR, et al. Performance of a real-time PCR assay for the detection of five candida species in blood samples from ICU patients at risk of candidemia. J Fungi (Basel), 2023, 9(6): 635. doi: 10.3390/jof9060635.

Clinical Microbiology Division of Henan Society of Microbiology, Microbiology and Immunology Branch of Henan Medical Association. Expert consensus on rapid detection of invasive fungal infection in Henan province. Henan Med Res, 2024,33(16): 2881-2887. doi: 10.3969/j.issn. 1004-437X.2024.16.001.


Refbacks

  • There are currently no refbacks.